FDA 21 CFR Part 11 is a US regulation specifying how electronic records and electronic signatures must be controlled to be trustworthy, reliable, and equivalent to paper records. Non‑technical stakeholders need to grasp that many digital tools must meet these criteria to be acceptable in regulated workflows.